Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Mobile. Study-provided care at no cost to qualified participants.
Access ulcerative colitis specialists in Mobile at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).This study will evaluate how safe and effective risankizumab is compared to vedolizumab in treating adult participants with moderate to severe UC who are naive to targeted therapies (TaTs). Risankizumab and vedolizumab are approved medications for moderate to severe UC in multiple countries. Participants who meet the eligibility criteria
Sponsor: AbbVie
Check if you qualify for this ulcerative colitis clinical trial in Mobile, AL
If you're searching for ulcerative colitis treatment options in Mobile, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mobile research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.